Dulla Naveen Kumar

Employment

• Case Western Reserve University Postdoctoral fellow
  2025 - Present

Education

• Indian Institute of Technology BHU Ph.D.
  2020 - 2025
• Mother Teresa PG College Degree student
  2013 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-026-03561-w
  +Save
• Ratiometric Combinatorial Delivery of Docetaxel and Erlotinib via Folate-Functionalized Nanostructured Lipid Carriers for Enhanced TNBC Treatment
  2026 DOI: 10.2139/ssrn.6819795
  +Save
• Exosomes improved the in vitro anti-melanoma efficacy of dihydroartemisinin
  Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari

  +3 more

  • Armin M. Gamper
  • Dinesh K. Kumar
  • Ashish Kumar Agrawal
  Journal of Drug Delivery Science and Technology 2024 DOI: 10.1016/j.jddst.2024.105957
  +Save
• Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach
  Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava +5 more
  Pharmaceutics 2024 DOI: 10.3390/pharmaceutics16070926
  +Save
• Quality by design–based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy
  Debadatta Mohapatra, Dulla Naveen Kumar, Singh Shreya +4 more
  Drug Delivery and Translational Research 2023 DOI: 10.1007/s13346-023-01375-y
  +Save
• A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds
  Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar +6 more
  Pharmaceuticals 2023 DOI: 10.3390/ph16070942
  +Save
• Quality-By-Design-Based Development of Ultradeformable Nanovesicular Transgelosome of Standardized Piper Longum Extract for Melanoma
  Debadatta Mohapatra, Dulla Naveen Kumar, Singh Shreya +3 more
  Nanomedicine 2023 DOI: 10.2217/nnm-2023-0069
  +Save
• Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
  Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari +4 more
  Cancers 2023 DOI: 10.3390/cancers15092661
  +Save
• Nanotherapeutics in autophagy: a paradigm shift in cancer treatment
  Shloka Negi, Aiswarya Chaudhuri, Dulla Naveen Kumar +3 more
  Drug Delivery and Translational Research 2022 DOI: 10.1007/s13346-022-01125-6
  +Save
• Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
  Aiswarya Chaudhuri, Dulla Naveen Kumar, Rasheed Ahemad Shaik +5 more
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms231710068
  +Save
• Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
  Dulla Naveen Kumar, Aiswarya Chaudhuri, Deepa Dehari +7 more
  Life 2022 DOI: 10.3390/life12081143
  +Save
• Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
  Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari +5 more
  Pharmaceuticals 2022 DOI: 10.3390/ph15050542
  +Save
• Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
  Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil +5 more
  Cancers 2022 DOI: 10.3390/cancers14061435
  +Save
• Triphenylphosphonium functionalized Ficus religiosa L. extract loaded nanoparticles improve the mitochondrial function in oxidative stress induced diabetes
  Karunanidhi Priyanka, Nitin Verma, Dulla Naveen Kumar +2 more
  AAPS PharmSciTech 2021 DOI: 10.1208/s12249-021-02016-8
  +Save